MARKET INTRODUCTION
Mebeverine is an antispasmodic medicine used to relax the muscles in the intestine. This medicine relieves symptoms caused due to irritable bowel syndrome like abdominal pain and cramps, stomach bloating, and diarrhea alternating with constipation. It is available in the form of slow release capsules, tablets and also in the form of liquid for those having trouble in swallowing tablets. It is a generic medicine available on prescription globally under many brand names.
MARKET DYNAMIC
Factors driving the mebeverine market's growth are changing lifestyle and eating habits, and the ease of availability of the medicine. However, certain side effects like mild itchy skin rash or swelling are likely to hinder the market's growth.
MARKET SCOPE
The "Mebeverine Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of mebeverine market with detailed market segmentation by type, and distribution channel. The mebeverine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in mebeverine market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The mebeverine market is segmented on the basis of type, and distribution channel. On the basis of type, the market is categorized as liquid, capsules, and tablets. On the basis of distribution channel the market is categorized as hospital pharmacy, retail pharmacy, online pharmacy, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the mebeverine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The mebeverine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting mebeverine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the mebeverine market in these regions.
MARKET PLAYERS
The report covers key developments in the mebeverine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from mebeverine market are anticipated to have lucrative growth opportunities in the future with the rising demand for mebeverine in the global market. Below mentioned is the list of few companies engaged in the mebeverine market.
The report also includes the profiles of key players in mebeverine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.
- Mylan
- Abbott
- Dr. Reddy's
- Puren Pharma
- Swiss Pharm
- Berlin Pharmaceutical
- Eipico Pharmaceutical
- USV Private Limited
- Pharco
- Aurovitas Pharma
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. PUBLISHERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Mebeverine Market - By Type
1.3.2 Mebeverine Market - By Distribution Channel
1.3.3 Mebeverine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MEBEVERINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MEBEVERINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MEBEVERINE MARKET - GLOBAL MARKET ANALYSIS
6.1. MEBEVERINE - GLOBAL MARKET OVERVIEW
6.2. MEBEVERINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MEBEVERINE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. LIQUID
7.3.1. Overview
7.3.2. Liquid Market Forecast and Analysis
7.4. CAPSULES
7.4.1. Overview
7.4.2. Capsules Market Forecast and Analysis
7.5. TABLETS
7.5.1. Overview
7.5.2. Tablets Market Forecast and Analysis
8. MEBEVERINE MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACY
8.3.1. Overview
8.3.2. Hospital Pharmacy Market Forecast and Analysis
8.4. RETAIL PHARMACY
8.4.1. Overview
8.4.2. Retail Pharmacy Market Forecast and Analysis
8.5. ONLINE PHARMACY
8.5.1. Overview
8.5.2. Online Pharmacy Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. MEBEVERINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Mebeverine Market Overview
9.1.2 North America Mebeverine Market Forecasts and Analysis
9.1.3 North America Mebeverine Market Forecasts and Analysis - By Type
9.1.4 North America Mebeverine Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Mebeverine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Mebeverine Market
9.1.5.1.1 United States Mebeverine Market by Type
9.1.5.1.2 United States Mebeverine Market by Distribution Channel
9.1.5.2 Canada Mebeverine Market
9.1.5.2.1 Canada Mebeverine Market by Type
9.1.5.2.2 Canada Mebeverine Market by Distribution Channel
9.1.5.3 Mexico Mebeverine Market
9.1.5.3.1 Mexico Mebeverine Market by Type
9.1.5.3.2 Mexico Mebeverine Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Mebeverine Market Overview
9.2.2 Europe Mebeverine Market Forecasts and Analysis
9.2.3 Europe Mebeverine Market Forecasts and Analysis - By Type
9.2.4 Europe Mebeverine Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Mebeverine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Mebeverine Market
9.2.5.1.1 Germany Mebeverine Market by Type
9.2.5.1.2 Germany Mebeverine Market by Distribution Channel
9.2.5.2 France Mebeverine Market
9.2.5.2.1 France Mebeverine Market by Type
9.2.5.2.2 France Mebeverine Market by Distribution Channel
9.2.5.3 Italy Mebeverine Market
9.2.5.3.1 Italy Mebeverine Market by Type
9.2.5.3.2 Italy Mebeverine Market by Distribution Channel
9.2.5.4 Spain Mebeverine Market
9.2.5.4.1 Spain Mebeverine Market by Type
9.2.5.4.2 Spain Mebeverine Market by Distribution Channel
9.2.5.5 United Kingdom Mebeverine Market
9.2.5.5.1 United Kingdom Mebeverine Market by Type
9.2.5.5.2 United Kingdom Mebeverine Market by Distribution Channel
9.2.5.6 Rest of Europe Mebeverine Market
9.2.5.6.1 Rest of Europe Mebeverine Market by Type
9.2.5.6.2 Rest of Europe Mebeverine Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Mebeverine Market Overview
9.3.2 Asia-Pacific Mebeverine Market Forecasts and Analysis
9.3.3 Asia-Pacific Mebeverine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Mebeverine Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Mebeverine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Mebeverine Market
9.3.5.1.1 Australia Mebeverine Market by Type
9.3.5.1.2 Australia Mebeverine Market by Distribution Channel
9.3.5.2 China Mebeverine Market
9.3.5.2.1 China Mebeverine Market by Type
9.3.5.2.2 China Mebeverine Market by Distribution Channel
9.3.5.3 India Mebeverine Market
9.3.5.3.1 India Mebeverine Market by Type
9.3.5.3.2 India Mebeverine Market by Distribution Channel
9.3.5.4 Japan Mebeverine Market
9.3.5.4.1 Japan Mebeverine Market by Type
9.3.5.4.2 Japan Mebeverine Market by Distribution Channel
9.3.5.5 Rest of Asia-Pacific Mebeverine Market
9.3.5.5.1 Rest of Asia-Pacific Mebeverine Market by Type
9.3.5.5.2 Rest of Asia-Pacific Mebeverine Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Mebeverine Market Overview
9.4.2 Middle East and Africa Mebeverine Market Forecasts and Analysis
9.4.3 Middle East and Africa Mebeverine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Mebeverine Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Mebeverine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Mebeverine Market
9.4.5.1.1 South Africa Mebeverine Market by Type
9.4.5.1.2 South Africa Mebeverine Market by Distribution Channel
9.4.5.2 Saudi Arabia Mebeverine Market
9.4.5.2.1 Saudi Arabia Mebeverine Market by Type
9.4.5.2.2 Saudi Arabia Mebeverine Market by Distribution Channel
9.4.5.3 U.A.E Mebeverine Market
9.4.5.3.1 U.A.E Mebeverine Market by Type
9.4.5.3.2 U.A.E Mebeverine Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Mebeverine Market
9.4.5.4.1 Rest of Middle East and Africa Mebeverine Market by Type
9.4.5.4.2 Rest of Middle East and Africa Mebeverine Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Mebeverine Market Overview
9.5.2 South and Central America Mebeverine Market Forecasts and Analysis
9.5.3 South and Central America Mebeverine Market Forecasts and Analysis - By Type
9.5.4 South and Central America Mebeverine Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Mebeverine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Mebeverine Market
9.5.5.1.1 Brazil Mebeverine Market by Type
9.5.5.1.2 Brazil Mebeverine Market by Distribution Channel
9.5.5.2 Argentina Mebeverine Market
9.5.5.2.1 Argentina Mebeverine Market by Type
9.5.5.2.2 Argentina Mebeverine Market by Distribution Channel
9.5.5.3 Rest of South and Central America Mebeverine Market
9.5.5.3.1 Rest of South and Central America Mebeverine Market by Type
9.5.5.3.2 Rest of South and Central America Mebeverine Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MEBEVERINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MEBEVERINE MARKET, KEY COMPANY PROFILES
12.1. MYLAN
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. DR. REDDY'S
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PUREN PHARMA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SWISS PHARM
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BERLIN PHARMACEUTICAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. EIPICO PHARMACEUTICAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. USV PRIVATE LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PHARCO
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. AUROVITAS PHARMA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT PUBLISHERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Mylan
2. Abbott
3. Dr. Reddy's
4. Puren Pharma
5. Swiss Pharm
6. Berlin Pharmaceutical
7. Eipico Pharmaceutical
8. USV Private Limited
9. Pharco
10. Aurovitas Pharma
Global Soft Mist Inhaler Market Report -..
This report elaborates the market size, market characteris..
+1-646-791 7070US (Toll Free)